Filters
| Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
|---|---|---|---|
Hereditary Prostate Cancer Panel QDx Pathology Services, Inc. United States | 4 | 16 |
|
Hereditary Pancreatic Cancer Panel Clariti Diagnostics Laboratories LLC United States | 4 | 15 |
|
Hereditary Cancer Panel Comprehensive Molecular Genetics Laboratory London Health Sciences Centre Canada | 39 | 30 |
|
PathGroup United States | 13 | 1 |
|
GeneID Lab - Advanced Molecular Diagnostics United States | 60 | 34 |
|
Hereditary Pancreatic Cancer (BRCA2, PALB2) GeneKor MSA Greece | 2 | 2 |
|
Hereditary Melanoma and/or Pancreatic Cancer, CDKN2A Gene GeneKor MSA Greece | 3 | 1 |
|
Invitae Expanded Renal Disease Panel Invitae United States | 693 | 388 |
|
Invitae United States | 59 | 16 |
|
Centogene AG - the Rare Disease Company Germany | 218 | 135 |
|
Centogene AG - the Rare Disease Company Germany | 74 | 34 |
|
Centogene AG - the Rare Disease Company Germany | 4 | 1 |
|
Centogene AG - the Rare Disease Company Germany | 12 | 1 |
|
SMAD4 - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 4 | 1 |
|
STK11 - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 4 | 1 |
|
TP53 - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 12 | 1 |
|
Centogene AG - the Rare Disease Company Germany | 27 | 29 |
|
Invitae Connective Tissue Disorders Panel Invitae United States | 195 | 92 |
|
Invitae Multi-Cancer + RNA Panel Invitae United States | 143 | 63 |
|
Invitae Common Hereditary Cancers + RNA Panel Invitae United States | 114 | 47 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.